Vimarsana
Biggest News Aggregation in the World

Page 2 - Jodi Akin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jodi Akin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jodi Akin Today - Breaking & Trending Today

2023 Connecticut Healthcare Legislation Summary - Healthcare - Vimarsana News

2023 Connecticut Healthcare Legislation Summary - Healthcare

In its 2023 regular session, the General Assembly made a number of changes to the statutes that affect healthcare providers in Connecticut.

Source: mondaq.com
Breaking Down New FDA Rules on Decentralized Clinical Trials - Vimarsana News

Breaking Down New FDA Rules on Decentralized Clinical Trials

Foley and Lardner attorneys discuss new Food and Drug Administration guidance on decentralized clinical trials for medication and medical devices and its impacts with health care executive Jodi Akin in this Podcast.

What has Covid-19 taught us about virtual clinical trials? - Vimarsana News

What has Covid-19 taught us about virtual clinical trials?

At the upcoming INVEST PharmaTech virtual conference scheduled for July 26, the conversations will span myriad topics at the intersection of digital health and drug development. Register today.

Hawthorne Effect Completes $20 Million Series A Round of Financing to Decentralize Clinical Trials - Vimarsana News

Hawthorne Effect Completes $20 Million Series A Round of Financing to Decentralize Clinical Trials

/PRNewswire/ -- Hawthorne Effect™, a solution for decentralizing clinical trials, today announced the successful closing of a $20 million Series A round of...

Hawthorne finishes off $20M series A to boost cloud-based siteless trials work - Vimarsana News

Hawthorne finishes off $20M series A to boost cloud-based siteless trials work

Northpond Ventures, SignalFire and P5 Health Ventures have helped San Francisco-based clinical trial software firm Hawthorne Effect complete a $20 million first formal funding round.